WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience PeproTech - Your Source for Neuroscience Research Reagents
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (48)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felts, P. A.
Right arrow Articles by Smith, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felts, P. A.
Right arrow Articles by Smith, K. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Spinal Cord Diseases

 Previous Article  |  Next Article 

Volume 17, Number 19, Issue of October 1, 1997 pp. 7267-7277
Copyright ©1997 Society for Neuroscience

Conduction in Segmentally Demyelinated Mammalian Central Axons

Received April 24, 1997; revised July 16, 1997; accepted July 18, 1997.

Paul A. Felts , Theresa A. Baker , and Kenneth J. Smith

Department of Neurology, United Medical and Dental Schools of Guy's and St. Thomas' Hospitals, Guy's Campus, London, SE1 9RT United Kingdom

The prominent symptoms associated with central demyelinating diseases such as multiple sclerosis (MS) are primarily caused by conduction deficits in affected axons. The symptoms may go into remission, but the mechanisms underlying remissions are uncertain. One factor that could be important is the restoration of conduction to affected axons, but it is not known whether demyelinated central axons resemble their peripheral counterparts in being able to conduct in the absence of repair by remyelination. In the present study we have made intra-axonal recordings from central axons affected by a demyelinating lesion, and then the axons have been labeled ionophoretically to permit their subsequent identification. Ultrastructural examination of 23 labeled preparations has established that some segmentally demyelinated central axons can conduct, and that they can do so over continuous lengths of demyelination exceeding several internodes (2500 µm). Such segmentally demyelinated central axons were found to conduct with the anticipated reduction in velocity and a refractory period of transmission (RPT) as much as 34 times the value obtained from the nondemyelinated portion of the same axon; the RPT was typically prolonged to 2-5 times the normal value. We conclude that some segmentally demyelinated central axons can conduct, and we propose that the restoration of conduction to such axons is likely to contribute to the remissions commonly observed in diseases such as MS.

Key words: demyelination; multiple sclerosis; axon; conduction properties; glia; ionophoresis




This article has been cited by other articles:


Home page
NeurologyHome page
R. Dutta and B. D. Trapp
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Neurology, May 29, 2007; 68(22_suppl_3): S22 - S31.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
O. W. Howell, A. Palser, A. Polito, S. Melrose, B. Zonta, C. Scheiermann, A. J. Vora, P. J. Brophy, and R. Reynolds
Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis
Brain, December 1, 2006; 129(12): 3173 - 3185.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Xie, J. X. Xiao, G. L. Gong, Y. F. Zang, Y. H. Wang, H. K. Wu, and X. X. Jiang
Voxel-based detection of white matter abnormalities in mild Alzheimer disease
Neurology, June 27, 2006; 66(12): 1845 - 1849.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. A. Black, S. G. Waxman, and K. J. Smith
Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier
Brain, May 1, 2006; 129(5): 1319 - 1329.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Vollmer, P. A. Leake, R. E. Beitel, S. J. Rebscher, and R. L. Snyder
Degradation of Temporal Resolution in the Auditory Midbrain After Prolonged Deafness Is Reversed by Electrical Stimulation of the Cochlea
J Neurophysiol, June 1, 2005; 93(6): 3339 - 3355.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. E. Hanak, E. M. Reilly, J. Wotanis, B. Zhu, C. Pulicicchio, K. McMonagle-Strucko, J. G. Wettstein, and M. D. Black
An Electrophysiological Model of Spinal Transmission Deficits in Mouse Experimental Autoimmune Encephalomyelitis
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Cappelen-Smith, C. S.-Y. Lin, S. Kuwabara, and D. Burke
Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy
Brain, August 1, 2002; 125(8): 1850 - 1858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Mead, S. K. Singhrao, J. W. Neal, H. Lassmann, and B. P. Morgan
The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury
J. Immunol., January 1, 2002; 168(1): 458 - 465.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. G. Waxman
Acquired channelopathies in nerve injury and MS
Neurology, June 26, 2001; 56(12): 1621 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Jasmin, G. Janni, T. M. Moallem, D. A. Lappi, and P. T. Ohara
Schwann Cells Are Removed from the Spinal Cord after Effecting Recovery from Paraplegia
J. Neurosci., December 15, 2000; 20(24): 9215 - 9223.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. G. Waxman
Multiple Sclerosis as a Neuronal Disease
Arch Neurol, January 1, 2000; 57(1): 22 - 24.
[Full Text] [PDF]


Home page
NEJMHome page
S. G. Waxman
Demyelinating Diseases -- New Pathological Insights, New Therapeutic Targets
N. Engl. J. Med., January 29, 1998; 338(5): 323 - 325.
[Full Text]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-